Announcements Trials
Browse Landscape

Phase

Phase 3 9Phase 2 8Phase 1 4Phase 2/3 2Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 4Recurrence 2Brain Neoplasms 2Astrocytoma 2Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Glioma 1Central Nervous System Neoplasms 1

Interventions

Lomustine 2Gefitinib 2Carboplatin 2trofosfamide 1tozuleristide 1entrectinib 1Vincristine 1Thiotepa 1Temozolomide 1Sunitinib 1Radiotherapy 1Methylprednisolone 1Maintenance Chemotherapy 1Magnetic Resonance Spectroscopy 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Diploidy 1Dexamethasone 1Cyclophosphamide 1Cisplatin 1Cholecalciferol 1Bevacizumab 1Adrenal Cortex Hormones 1AZD3759 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Brain Neoplasms × Lomustine × Clear all
NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Universitätsklinikum Hamburg-Eppendorf

Phase 2/3 Active not recruiting
360 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT03025893 2021-04-19

STELLAR

Amsterdam UMC, location VUmc

Phase 2/3 Unknown
100 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡